PNC FINANCIAL SERVICES GROUP, INC. - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 85 filers reported holding KALA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 7.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$02160.0%0.00%
Q4 2021$0
-100.0%
216
-69.0%
0.00%
Q3 2021$1,000
-80.0%
6960.0%0.00%
Q2 2021$5,0000.0%6960.0%0.00%
Q1 2021$5,0000.0%6960.0%0.00%
Q4 2020$5,000
-16.7%
6960.0%0.00%
Q3 2020$6,000
-14.3%
6960.0%0.00%
Q2 2020$7,000
+16.7%
6960.0%0.00%
Q1 2020$6,000
+500.0%
696
+13.0%
0.00%
Q4 2019$1,000
-50.0%
616
+12.0%
0.00%
Q3 2019$2,000
-33.3%
5500.0%0.00%
Q2 2019$3,000
-25.0%
550
-7.3%
0.00%
Q1 2019$4,000
+100.0%
593
+7.8%
0.00%
Q4 2018$2,000
-33.3%
550
+57.1%
0.00%
Q3 2018$3,000
-25.0%
3500.0%0.00%
Q2 2018$4,000
-20.0%
3500.0%0.00%
Q1 2018$5,000
-16.7%
3500.0%0.00%
Q4 2017$6,0003500.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CAXTON CORP 1,142,360$7,745,0004.83%
RA Capital Management 10,874,613$73,730,0001.03%
Mesirow Financial Investment Management, Inc. 43,431$294,462,0000.93%
Parkman Healthcare Partners LLC 272,445$1,847,0000.47%
Samsara BioCapital, LLC 601,162$4,076,0000.41%
SILVERARC CAPITAL MANAGEMENT, LLC 102,198$693,0000.40%
Eventide Asset Management 3,450,000$23,391,0000.36%
Orbimed Advisors 5,465,030$37,053,0000.32%
Vivo Capital, LLC 786,883$5,335,0000.24%
Knights of Columbus Asset Advisors LLC 169,429$1,149,0000.12%
View complete list of KALA PHARMACEUTICALS INC shareholders